BBK Capital Partners »

Corcept Therapeutics Incorporated shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $720k 8.7k 83.11
2025-06-30 $636k 8.7k 73.40
2025-03-31 $892k 7.8k 114.22

More positions owned by BBK Capital Partners

Procter & Gamble Company (PG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Etf Opportunities Trust Formidable Fortr (KONG)
Etf Opportunities Trust Formidable Etf (FORH)
Chemed Corp Com Stk (CHE)
Eli Lilly & Co. (LLY)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Gamco Global Gold Nat Res & Com Sh Ben Int (GGN)

View all positions for BBK Capital Partners

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated